These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2302013)

  • 1. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
    Abinader EG; Cooper M
    JAMA; 1979 Jul; 242(4):337-9. PubMed ID: 448936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
    Horowitz LN; Greenspan AM; Spielman SR; Frye SJ; Yacone LA; Lowenthal DT
    Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography].
    Garimoldi M; Pirastu A; Barbanotti G; Sghirinzetti M; Catalano M; Castelfranco M
    Minerva Cardioangiol; 1988 Apr; 36(4):159-65. PubMed ID: 3173699
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
    Giardina EG; Wechsler ME
    J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia.
    Ravid S; Lampert S; Graboys TB
    Clin Cardiol; 1991 Dec; 14(12):951-5. PubMed ID: 1726725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH; Chiale PA; Bandieri JD; Lázzari JO; Elizari MV; Rosenbaum MB
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.